Literature DB >> 20486255

Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry.

A Vonaparti1, E Lyris, Y S Angelis, I Panderi, M Koupparis, A Tsantili-Kakoulidou, R J B Peters, M W F Nielen, C Georgakopoulos.   

Abstract

Unification of the screening protocols for a wide range of doping agents has become an important issue for doping control laboratories. This study presents the development and validation of a generic liquid chromatography/time-of-flight mass spectrometry (LC/TOFMS) screening method of 241 small molecule analytes from various categories of prohibited substances (stimulants, narcotics, diuretics, beta(2)-agonists, beta-blockers, hormone antagonists and modulators, glucocorticosteroids and anabolic agents). It is based on a single-step liquid-liquid extraction of hydrolyzed urine and the use of a rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometric system acquiring continuous full scan data. Electrospray ionization in the positive mode was used. Validation parameters consisted of identification capability, limit of detection, specificity, ion suppression, extraction recovery, repeatability and mass accuracy. Detection criteria were established on the basis of retention time reproducibility and mass accuracy. The suitability of the methodology for doping control was demonstrated with positive urine samples. The preventive role of the method was proved by the case where full scan acquisition with accurate mass measurement allowed the retrospective reprocessing of acquired data from past doping control samples for the detection of a designer drug, the stimulant 4-methyl-2-hexanamine, which resulted in re-reporting a number of stored samples as positives for this particular substance, when, initially, they had been reported as negatives. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486255     DOI: 10.1002/rcm.4554

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  5 in total

1.  The chromatographic role in high resolution mass spectrometry for non-targeted analysis.

Authors:  Timothy R Croley; Kevin D White; John H Callahan; Steven M Musser
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-19       Impact factor: 3.109

2.  Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens.

Authors:  Fessessework Guale; Shahriar Shahreza; Jeffrey P Walterscheid; Hsin-Hung Chen; Crystal Arndt; Anna T Kelly; Ashraf Mozayani
Journal:  J Anal Toxicol       Date:  2012-11-01       Impact factor: 3.367

Review 3.  The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.

Authors:  Amy B Cadwallader; Carol S Lim; Douglas E Rollins; Francesco Botrè
Journal:  J Anal Toxicol       Date:  2011-11       Impact factor: 3.367

4.  Identification and profiling of targeted oxidized linoleic acid metabolites in rat plasma by quadrupole time-of-flight mass spectrometry.

Authors:  Zhi-Xin Yuan; Stanley I Rapoport; Steven J Soldin; Alan T Remaley; Ameer Y Taha; Matthew Kellom; Jianghong Gu; Maureen Sampson; Christopher E Ramsden
Journal:  Biomed Chromatogr       Date:  2012-10-05       Impact factor: 1.902

5.  Detection of β-methylphenethylamine, a novel doping substance, by means of UPLC/MS/MS.

Authors:  Piotr Chołbiński; Mariola Wicka; Katarzyna Kowalczyk; Anna Jarek; Paweł Kaliszewski; Andrzej Pokrywka; Ewa Bulska; Dorota Kwiatkowska
Journal:  Anal Bioanal Chem       Date:  2014-03-16       Impact factor: 4.142

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.